Linical Co., Ltd. (TYO:2183)
Japan · Delayed Price · Currency is JPY 317.00
+1.00 (0.32%)
Mar 6, 2026, 3:30 PM JST
Linical Market Cap
Linical has a market cap or net worth of 7.16 billion as of March 6, 2026. Its market cap has decreased by -8.65% in one year.
Market Cap
7.16B
Enterprise Value
4.36B
Revenue
9.32B
Ranking
n/a
PE Ratio
n/a
Stock Price
317.00
Market Cap Chart
Since October 27, 2008, Linical's market cap has decreased from 9.24B to 7.16B, a decrease of -22.51%. That is a compound annual growth rate of -1.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 7.16B | 8.19% |
| Dec 30, 2025 | 6.62B | -15.80% |
| Dec 30, 2024 | 7.86B | -34.34% |
| Dec 29, 2023 | 11.97B | -23.19% |
| Dec 30, 2022 | 15.58B | -11.31% |
| Dec 30, 2021 | 17.57B | 10.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BrightPath Biotherapeutics | 8.30B |
| MEDINET | 8.00B |
| ADR120S | 7.87B |
| Chiome Bioscience | 7.57B |
| CellSource | 7.53B |
| OncoTherapy Science | 7.53B |
| PRISM BioLab Co.,LTD | 6.69B |
| Soiken Holdings | 6.62B |